Evidence map›Paper›PMID 38607143›Full record

ArticleNanomaterials (Basel, Switzerland)2024

Fluorocarbon Plasma-Polymerized Layer Increases the Release Time of Silver Ions and the Antibacterial Activity of Silver-Based Coatings.

Linda Bonilla-Gameros, Pascale Chevallier, Xavier Delvaux, L Astrid Yáñez-Hernández, Laurent Houssiau, Xavier Minne, Vanessa P Houde, Andranik Sarkissian, Diego Mantovani

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Linda Bonilla-GamerosLaboratory for Biomaterials and Bioengineering, (CRC-Tier I), Department of Min-Met-Materials Eng and Regenerative Medicine, CHU de Quebec, Laval University, Quebec City, QC G1V 0A6, Canada.ORCID 0000-0002-6287-4112
Pascale ChevallierLaboratory for Biomaterials and Bioengineering, (CRC-Tier I), Department of Min-Met-Materials Eng and Regenerative Medicine, CHU de Quebec, Laval University, Quebec City, QC G1V 0A6, Canada.
Xavier DelvauxLaboratoire Interdisciplinaire de Spectroscopie Electronique, Namur Institute of Structured Matter, University of Namur, 61 Rue de Bruxelles, 5000 Namur, Belgium.
L Astrid Yáñez-HernándezLaboratory for Biomaterials and Bioengineering, (CRC-Tier I), Department of Min-Met-Materials Eng and Regenerative Medicine, CHU de Quebec, Laval University, Quebec City, QC G1V 0A6, Canada.ORCID 0000-0003-3704-9505
Laurent HoussiauLaboratoire Interdisciplinaire de Spectroscopie Electronique, Namur Institute of Structured Matter, University of Namur, 61 Rue de Bruxelles, 5000 Namur, Belgium.
Xavier MinneOral Ecology Research Group (GREB), Faculty of Dentistry, Université Laval, 2420 rue de la Terrasse, Quebec City, QC G1V 0A6, Canada.ORCID 0000-0002-0850-0187
Vanessa P HoudeOral Ecology Research Group (GREB), Faculty of Dentistry, Université Laval, 2420 rue de la Terrasse, Quebec City, QC G1V 0A6, Canada.ORCID 0000-0003-1932-805X
Andranik SarkissianPlasmionique Inc., 171-1650 Boul Lionel Boulet, Varennes, QC J3X1S2, Canada.ORCID 0000-0003-4051-595X
Diego MantovaniLaboratory for Biomaterials and Bioengineering, (CRC-Tier I), Department of Min-Met-Materials Eng and Regenerative Medicine, CHU de Quebec, Laval University, Quebec City, QC G1V 0A6, Canada.ORCID 0000-0001-9672-895X
Université Laval · CAUniversity of Namur · BEPlasmionique (Canada) · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silver-based antibacterial coatings limit the spread of hospital-acquired infections. Indeed, the use of silver and silver oxide nanoparticles (Ag and AgO NPs) incorporated in amorphous hydrogenated carbon (a-C:H) as a matrix demonstrates a promising approach to reduce microbial contamination on environmental surfaces. However, its success as an antibacterial coating hinges on the control of Ag

Indexed as

amorphous hydrogenated carbonfluoropolymerlow pressure plasmasilver nanoparticles

Identifiers

PMID38607143
PMCPMC11013325
OpenAlexW4393352667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.